Therapeutic Neovascularization – Quo vadis?
Springer-Verlag New York Inc.
978-1-4020-5954-4 (ISBN)
Indeed, the scientific modifications of a fundamentally sound concept will enable its applicability in the not so distant future. The condensed collection of current views on neovascularization is intended to speed up this process.
Clinical Vascular Growth Factor Therapy for Neovascularization in Patients with Coronary Artery Disease.- The Strengths and Weaknesses of VEGF Adenovirus-Driven Angiogenesis.- Angiogenesis and Arteriogenesis in Diabetes Mellitus: Signal Transduction Defects as the Molecular Basis of Vascular Cell Dysfunction.- Endothelial Activation and Neointimal Hyperplasia: A Double-Edged Sword.- Pampering and Priming the Heart.- Coronary Venous Retroinfusion: A Novel Venue of Regional Induction of Neovascularization.- Integrative Pro-angiogenic Activation: HIF-?.- The Maturation of Vessels – A Limitation to Forced Neovascularization?.- Vascular and Neuronal Development: Intersecting Parallelisms and rossroads.- Cathelicidin Antimicrobial Peptides Modulate Angiogenesis.- The Biology of Embryonic and Adult Endothelial Progenitor Cells.- Signaling Behind Progenitor Cell Mobilization: Focus on Enos and Caveolin.- The Role of Monocytes/Macrophages and Vascular Resident Precursor Cells in Collateral Growth.
Zusatzinfo | X, 262 p. |
---|---|
Verlagsort | New York, NY |
Sprache | englisch |
Maße | 155 x 235 mm |
Themenwelt | Studium ► 1. Studienabschnitt (Vorklinik) ► Physiologie |
ISBN-10 | 1-4020-5954-X / 140205954X |
ISBN-13 | 978-1-4020-5954-4 / 9781402059544 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich